| Class 2 Device Recall Hospilak, Portex First Breath, MediChoice | |
Date Initiated by Firm | January 07, 2011 |
Date Posted | February 15, 2011 |
Recall Status1 |
Terminated 3 on February 27, 2013 |
Recall Number | Z-1255-2011 |
Recall Event ID |
57626 |
Product Classification |
oxygen mask - Product Code BYL
|
Product | Face Tent
Hospilak Ref. No. 110-E, Face Tent, Adult No Tubing, Manufactured for Unomedical inc.
Hospilak Ref. No. 111-E, Face Tent, Adult No Tubing, with 15mm OD Connector Manufactured for Unomedical inc.
Hospilak Ref. No. 115-E, Face Tent, Adult 5 (1.5m) Tubing Manufactured for Unomedical inc.
Hospilak Ref. No. 116-E, Face Tent, Adult 6 (1.8 m) Aerosol Tubing Manufactured for Unomedical inc.
McKesson Aerosol Mask, Face Tent Adult, No Tubing Reorder No. 86-110E
Face Tent Adult, 6 (1.8m) Aerosol Tubing Reorder no. 86-116E
Smiths Medical Portex First Breath Adult Face Tent (Non-latex) Ref 001490
Smiths Medical Portex First Breath Adult Face Tent with Tubing, 188cm (5 ft.) (Non-latex) Ref 001492
Owens & Minor MediChoice Adult Face Tent Re-Order #RSP3000 and Face Tent, Adult 6 (1.8m) Aerosol Tubing Re-Order #RSP3060 |
Code Information |
Numerous lots produced between June 2009 and September 2010. |
Recalling Firm/ Manufacturer |
Convatec Inc. 200 Headquarters Park Drive Skillman NJ 08558-2600
|
For Additional Information Contact | Ms. Barbara DeLade 908-904-2675 |
Manufacturer Reason for Recall | Face tents and Oxygen masks may have a sticky glue-like substance on the inside or outside of the mask consisting of dioctyl phthalate, epoxidized soybean oil and glycerol monoleate. |
FDA Determined Cause 2 | Nonconforming Material/Component |
Action | Unomedical, Inc issued recall letters with attached return response forms dated January 7, 2011 via UPS. The letters request the customer stop use and quarantine product. The recall response form is to be completed and returned to Unomedical.
The letters/return response form were also sent out in Spanish.
Another recall letter was sent dated February 16, 2011 to capture additional lots that werent included in the initial letter. |
Quantity in Commerce | 1579100 pcs. |
Distribution | Worldwide distribution, including USA, Puerto Rico, Canada, Mexico, Colombia, El Salvador, Paraguay, UK, Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Faroe Islands, Finland, France, Germany, Hungary, Iceland, Ireland, Italy, Netherlands, Norway, Poland, Spain, Sweden and Switzerland, Israel, Jordan, Lebanon, Libya, Morocco, Saudi Arabia, United
Arab Emirates, Russia, Australia, New Zealand,
Japan and Vietnam. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|